Medistem

Cell Therapy / Regenerative Medicinemedisteminc.com

Medistem, founded in 2005, was a small San Diego-based biotechnology company focused on developing and commercializing adult stem cell-based therapeutic products. Its corporate domain is currently listed for sale, indicating the company is likely dormant or in wind-down.

Company typePrivate
Founded2005
HeadquartersSan Diego, United States
Headcount1–10
GTM typeB2B
OfferingHardware or Manufacturing

What Medistem does

Medistem is a privately held, for-profit biotechnology company founded in 2005 and based in San Diego, California. Per the available record, its stated mission is to develop, acquire, and commercialize adult stem cell-based therapeutic products, positioning it within the cell therapy segment of the biotech industry. The company operates with a very small team of 1-10 employees and historically has been led by a four-person executive team: Alan Lewis (CEO), John P. Salvador (COO), Donald Dickerson (CFO), and Thomas Ichim (President & CSO). The only capital event documented is a funding round dated February 2012 with undisclosed terms.

The current operational status of Medistem is unclear and likely inactive. The company's web domain, medisteminc.com, is listed for sale on HugeDomains at $3,595, indicating the corporate website is no longer in active use — a strong indicator of dormancy, wind-down, or corporate dissolution. No active products, clinical pipeline data, partnerships, customer relationships, regulatory designations, or revenue figures are disclosed in the available source material. With no post-2012 strategic activity on record and no maintained corporate web presence, the input does not support any inference of ongoing commercial operations; the most defensible reading is that Medistem is dormant or has ceased operations in its prior form.

Medistem firmographics

Firmographics

Name: Medistem
Website: https://medisteminc.com
Company type: Private
Founded year: 2005
Operating status: Unknown
Headcount range: 1–10 employees
Short description: Medistem, founded in 2005, was a small San Diego-based biotechnology company focused on developing and commercializing adult stem cell-based therapeutic products. Its corporate domain is currently listed for sale, indicating the company is likely dormant or in wind-down.
Ownership category
akta.pro rank

Medistem industry classification

Industry

Product category: Cell Therapy / Regenerative Medicine
NAICS: Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC: Biological Products, (No Disgnostic Substances) (2836), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry: Stem Cell–Based Regenerative Therapies (HLAAAGAA)
akta.pro secondary industries: Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Cell Therapy Developers (Autologous) (HLAAABAA)

Keywords

Adult stem cell therapies
Regenerative medicine
Cell therapy development
Stem cell therapeutics
Biomedical therapeutics

Where Medistem is headquartered

Location

Headquarters

HQ city: San Diego
HQ country: United States
HQ region: North America

Markets served

Medistem business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Personnel, Technology or R&D, Operations

Medistem product offering

Product offering

Core offering

Medistem developed, acquired, and commercialized adult stem cell based therapeutic products. The company's core activity centered on advancing adult (non-embryonic) stem cell technologies for therapeutic applications. The firm's primary web domain is presently listed for sale, and active operations cannot be confirmed.

Differentiator

Problem solved

Functional benefit

Products and services

Adult Stem Cell Based Therapeutic Products Therapeutic products derived from adult stem cells that Medistem developed, acquired, and commercialized for healthcare providers and research/clinical customers.

Companies that use Medistem

Customer profile

Ideal customer profiles1 record

Medistem technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Medistem partnerships and signals

Strategic signal

Recent moves2 records

Medistem competitors and assessment

Company assessment

Market position

Strengths3 records

Competitive moat1 record

Key risks5 records

Key highlights3 records

Customer concentration

Medistem financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medistem leadership team

Management profile

Number of profiles

Profiles4 records

Medistem funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medistem M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medistem

What does Medistem do?

When was Medistem founded?

Medistem was founded in 2005. It employs 1 to 10 people.

Where is Medistem based?

Medistem is headquartered in San Diego, United States, in the North America region.

Does Medistem have an API?

No public API is recorded for Medistem.

What industry is Medistem in?

Medistem's product category is Cell Therapy / Regenerative Medicine. Its primary akta.pro industry code is HLAAAGAA, Stem Cell–Based Regenerative Therapies, with a secondary code of HLAAABAE, Stem Cell Therapies (MSC/iPSC/HSC-derived). Its NAICS code is 325414 and its SIC code is 2836.